Literature DB >> 30167864

Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.

Chao Yang1,2,3,4, He Cheng1,2,3,4, Yiyin Zhang1,2,3,4, Kun Fan1,2,3,4, Guopei Luo1,2,3,4, Zhiyao Fan1,2,3,4, Qiuyi Huang1,2,3,4, Yu Lu1,2,3,4, Kaizhou Jin1,2,3,4, Zhengshi Wang1,2,3,4, Xianjun Yu5,6,7,8, Chen Liu9,10,11,12.   

Abstract

INTRODUCTION: Natural killer cells (NK) are often believed to play a positive role in the antitumor immune response. However, this is not the case for patients with advanced pancreatic cancer. This study was performed to determine the unique subtype of "educated" NK cells and their prognostic value in patients with advanced pancreatic cancer.
METHODS: We divided 378 eligible patients into a derivation cohort (September 2010 to December 2014, n = 239) and a validation cohort (January 2015 to April 2016, n = 139). Flow cytometry was performed to analyze NK cells. Enzyme-linked immunosorbent assay was used to detect interleukin-2 (IL-2), interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) production. The Kaplan-Meier method and the Cox proportional hazards model were used.
RESULTS: Survival analysis showed that a high density of NK cells accompanied by a high neutrophil-to-lymphocyte ratio was associated with reduced overall survival in both the derivation and validation cohorts. Multivariable analysis also showed that high NK infiltration (HR 1.45, 95% CI 1.17 to 1.79, p = 0.001) was an independent prognostic factor. In these patients, high NK infiltration was associated with reduced levels of IL-2, IFN-γ and TNF-α, although only IFN-γ reached statistical significance, which accounted for this unique phenomenon. DISCUSSION: Natural killer cells in patients with advanced pancreatic cancer are a unique subtype with anergic features. A high density of NKs predicts poor survival in these patients, possibly because an active inflammatory response and reduced secretion of IL-2, IFN-γ and TNF-α inhibit NK activation.

Entities:  

Keywords:  Anergic; Dysfunction; Natural killer cells; Pancreatic cancer; Prognosis

Mesh:

Substances:

Year:  2018        PMID: 30167864     DOI: 10.1007/s00262-018-2235-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  8 in total

Review 1.  Advances in NK cell production.

Authors:  Fang Fang; Siqi Xie; Minhua Chen; Yutong Li; Jingjing Yue; Jie Ma; Xun Shu; Yongge He; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2022-01-05       Impact factor: 22.096

2.  Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients.

Authors:  Yitao Gong; Zhiyao Fan; Guopei Luo; Qiuyi Huang; Yunzhen Qian; He Cheng; Kaizhou Jin; Quanxing Ni; Xianjun Yu; Chen Liu
Journal:  Cancer Manag Res       Date:  2020-08-03       Impact factor: 3.989

3.  Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.

Authors:  Shuo Zhang; Weijian Liu; Binwu Hu; Peng Wang; Xiao Lv; Songfeng Chen; Zengwu Shao
Journal:  Front Immunol       Date:  2020-07-02       Impact factor: 7.561

4.  Percentage of Natural Killer (NK) Cells in Peripheral Blood Is Associated with Prognosis in Patients with Gastric Cancer: A Retrospective Study from a Single Center.

Authors:  Ming-Zhi Xie; Yan-Ping Tang; Bang-Li Hu; Ke-Zhi Li; Ji-Lin Li; Xin-Qiang Liang
Journal:  Med Sci Monit       Date:  2021-01-27

5.  Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations.

Authors:  Katalin Balázs; Zsuzsa S Kocsis; Péter Ágoston; Kliton Jorgo; László Gesztesi; Gyöngyi Farkas; Gábor Székely; Zoltán Takácsi-Nagy; Csaba Polgár; Géza Sáfrány; Zsolt Jurányi; Katalin Lumniczky
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

Review 6.  Natural killer cells in pancreatic cancer stroma.

Authors:  Rachel Elizabeth Ann Fincham; Francesca Romana Delvecchio; Michelle R Goulart; Joe Poe Sheng Yeong; Hemant M Kocher
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

Review 7.  Natural killer cells in cancer biology and therapy.

Authors:  Song-Yang Wu; Tong Fu; Yi-Zhou Jiang; Zhi-Ming Shao
Journal:  Mol Cancer       Date:  2020-08-06       Impact factor: 27.401

8.  Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.

Authors:  Yong Liu; Guangbing Li; Yang Yang; Ziwen Lu; Tao Wang; Xiaoyu Wang; Jun Liu
Journal:  Front Genet       Date:  2022-01-03       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.